Zongertinib

Records for this ingredient, by country (identity only).

ATC L01EH04 · 4 markets · 4 records

Zongertinib 4 markets · 4 records Forms

Filters

MarketUS 1 CA 1 HK 1 JP 1

Strength

US 1 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

60 mgtabletHERNEXEOS also in CA·JP

CA 1 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

60 mgtabletHERNEXEOS also in US·JP

HK 1 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名HERNEXEOS ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

JP 1 records · 1 shown of 1 Source 厚生労働省薬価基準収載品目リスト · Data as of 2026-11-01

60 mgtabletヘルネクシオス錠60mg also in US·CA

Side-by-side table

Strength / form / release	US	CA	HK	JP
60 mg tablet	HERNEXEOS	HERNEXEOS	not recorded	ヘルネクシオス錠60mg
not disclosed unknown	not recorded	not recorded	HERNEXEOS	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.